Pediatric Vaccines Market 2018-2026 : Health Improving Aspects
Discussed To Encourage Demand In Upcoming Years, Estimated
By Top Players GlaxoSmithKline plc, Eli Lilly Company, Pfizer,
Inc. , Aventis Pharma Limited
Pediatric vaccines perform significant role in reduction of various childhood infectious disease
such as measles, diphtheria, Poliomyelitis, and Haemophilus influenzae type b (Hib). Increasing
adoption of pediatric vaccines have significantly led to increase in global vaccination coverage.
According to the World Health Organization (WHO), immunization helps to prevent around 2 to
3 million deaths annually. Moreover, vaccination is the most cost–effective and efficient heath
investment, which is accessible to hard-to-reach locations and vulnerable populations. According
to the data published by Centers for Disease Control and Prevention (CDC), in April 2014,
vaccination was estimated to prevent around 21 million hospitalizations and around 732,000
deaths among children born between 1994 and 2013. High prevalence of infectious disease,
combined with increasing numbers of government initiatives for raising awareness regarding
immunization and development of novel adjuvants and therapeutic vaccines are expected to
drive growth of pediatric vaccines market during the forecast period.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1708
The global pediatric vaccines market was valued at US$ 23,317.0 million in 2017 and is
expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026)
Market Dynamics:
The Centers for Disease Control and Prevention (CDC) recommends immunizing children against
most of the vaccine preventable disease by the time they are two years old. These resulted in
elimination of some of the infectious disease completely in various countries. For instance, Polio
and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014,
World Health Organisation (WHO) declared India as polio-free nation.
Increasing prevalence of chronic and infectious disease, along with growing awareness regarding
childhood immunization among various developed and emerging economies lead to boost the
growth of pediatric vaccines market in near future. Furthermore, increasing alliances,